Skip to main content

Rockefeller University

!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Upcoming Event

TBA

Ph.D. Recruitment Lecture

Event Details

Type
Friday Lecture Series
Speaker(s)
Paul Bieniasz, Ph.D., professor and head, Laboratory of Retrovirology, The Rockefeller University; investigator, Howard Hughes Medical Institute
Event URL
http://go.rockefeller.edu/FLS_Bieniasz
Event password
460700
Speaker bio(s)

Paul Bieniasz received his bachelor’s degree in biochemistry from the University of Bath in 1990 and his Ph.D. in virology from the University of London in 1996. This was followed by a postdoc at Duke University from 1996 to 1999. From 1999 to 2016 Bieniasz was a staff investigator at the Aaron Diamond AIDS Research Center. In 1999, he also became an assistant professor at Rockefeller. He was appointed associate professor in 2003 and professor in 2010. He has been a Howard Hughes Medical Institute investigator since 2008.

This webinar will be recorded for the RU community. Please do not share the link or post on social media.

Open to
Public
Host
Marina Caskey
Contact
Cienna Tardy
Phone
(212) 327-7714
Sponsor
Cienna Tardy
(212) 327-7714
ctardy@rockefeller.edu

Add To Your Calendar

Related News

The immune system mounts a lasting defense after recovery from COVID-19

The study participants continued to improve their antibodies months after initial infection, potentially due to exposure to the remnants of the virus hidden in the gut.

The blood may hold clues to some of COVID-19’s most mysterious symptoms

COVID-19 causes a host of diverse complications, from lung inflammation to blood clots, heart failure, and brain fog. A team of scientists believes these attributes may have a single culprit—and that findings from research on Alzheimer’s disease might give them a leg up in finding it.

Rockefeller begins testing of new COVID-19 antibody drug in people

Patients in the clinical trial will receive two highly potent antibodies against SARS-CoV-2 discovered at the university. Designed to prevent people with early COVID-19 from developing severe disease, the treatment is urgently needed as hospitals continue to be inundated by repeated surges of infection, and mass vaccinations are still months away.

Related Events

| WEBINAR

[RESCHEDULED FOR 1/27/21] RiSI Diversity, Equity, Inclusion, and Justice Journal Club

The Diversity-Innovation Paradox in Science

| WEBINAR

Synthetic Lethality of Wnt Pathway Activation and Asparaginase for Cancer Therapy

| WEBINAR

Mechanisms of Transcriptional Regulation by Chromatin Adaptor Proteins

Calendar of Events & Lectures

Browse upcoming and past Events and Lectures by keyword, program, date and type

Contact

Cienna Tardy